Cas 25874-98-0,Hydrazinecarboxamide, 2-[(2-chlorophenyl)methylene]-N,N-dimethyl-

25874-98-0

Post Buying Request

Basic information

Product Name: Hydrazinecarboxamide, 2-[(2-chlorophenyl)methylene]-N,N-dimethyl-
Synonyms:
CAS NO:25874-98-0
Molecular Formula: C10H12ClN3O
Molecular Weight: 225.678
EINECS: N/A
Product Categories: N/A
Mol File: 25874-98-0.mol

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: Hydrazinecarboxamide, 2-[(2-chlorophenyl)methylene]-N,N-dimethyl-(CAS DataBase Reference)
NIST Chemistry Reference: Hydrazinecarboxamide, 2-[(2-chlorophenyl)methylene]-N,N-dimethyl-(25874-98-0)
EPA Substance Registry System: Hydrazinecarboxamide, 2-[(2-chlorophenyl)methylene]-N,N-dimethyl-(25874-98-0)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 25874-98-0(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

25874-98-0 Suppliers

Recommended suppliers

25874-98-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 25874-98-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,5,8,7 and 4 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 25874-98:
(7*2)+(6*5)+(5*8)+(4*7)+(3*4)+(2*9)+(1*8)=150
150 % 10 = 0
So 25874-98-0 is a valid CAS Registry Number.

25874-98-0Upstream product

25874-98-0Downstream Products

25874-98-0Relevant academic research and scientific papers

4 Substituted semicarbazones of mono and dichlorobenzaldehydes as antihypertensive agents

Warren,Woodward,Hargreaves

, p. 1520 - 1521 (2007/10/05)

Twelve 4-substituted semicarbazone derivatives of o- and p-chloro- as well as 2,6-dichlorobenzaldehyde were synthesized and investigated for antihypertensive activity in spontaneously hypertensive rats. Several of the compounds synthesized exhibited poten

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 25874-98-0